FLGT vs GRAL

Fulgent Genetics, Inc. vs GRAIL, Inc. — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — FLGT scores higher on quality with 7.1/10 vs GRAL's 7.0/10. FLGT trades at $18.70 while GRAL trades at $59.90. Both analyzed daily using SEC EDGAR data across 13 institutional models.

FLGT

Diagnostics & Research
Fulgent Genetics, Inc.
Quality
7.1
out of 10
Value Trap
12
SAFE
Price
$18.70
Last close
Models
12/13
Active
VS

GRAL

Diagnostics & Research
GRAIL, Inc.
Quality
7.0
out of 10
Value Trap
6
SAFE
Price
$59.90
Last close
Models
12/13
Active
FLGT
Bayesian DCF sees +227.1% upside
Limited to 2/13 visible models
GRAL
2 models active
Limited to 2/13 visible models

FLGT vs GRAL — Fair Value Comparison

FLGT
$0$24$48$72 Price$18.70 Bayesian …$61.16 (+227.1%) Earnings …$23.78 (+27.1%)
GRAL
$0$24$47$71 Price$59.90 Bayesian …$17.83 (-70.2%) Earnings …$34.28 (-37.0%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType FLGT Fair ValueFLGT Upside GRAL Fair ValueGRAL Upside
Bayesian DCF Intrinsic $61.16 +227.1% $17.83 -70.2%
Earnings Power Value Intrinsic $23.78 +27.1% $34.28 -37.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%

FLGT vs GRAL — Which Stock Is More Undervalued in 2026?

FLGT scores higher with a 7.1/10 quality rating vs GRAL's 7.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do FLGT and GRAL Valuations Compare?

At $18.70, FLGT trades +227.1% below its Bayesian DCF fair value of $61.16, while GRAL at $59.90 trades +70.2% above its estimate of $17.83. FLGT shows a wider gap between price and intrinsic value.

Quality of Company: FLGT vs GRAL

FLGT earns a Quality of Company score of 7.1/10 compared to GRAL's 7.0/10. The scores are closely matched, indicating similar fundamental quality profiles. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: FLGT vs GRAL

FLGT carries a SAFE value trap risk (12/100) while GRAL shows SAFE risk (6/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Diagnostics & Research

Both FLGT and GRAL operate in Diagnostics & Research, which has 48 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare FLGT vs GRAL differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

See all Diagnostics & Research stocks →